De novo thrombotic microangiopathy after kidney transplantation

N Garg, HG Rennke, M Pavlakis, K Zandi-Nejad - Transplantation Reviews, 2018 - Elsevier
Thrombotic microangiopathy (TMA) is a serious complication of transplantation that
adversely affects kidney transplant recipient and allograft survival. Post-transplant TMA is …

Approaching treatment of transplant‐associated thrombotic Microangiopathy from two directions with Eculizumab and transitioning from Tacrolimus to Sirolimus

AS Jan, C Hosing, F Aung, J Yeh - Transfusion, 2019 - Wiley Online Library
BACKGROUND In the past, conventional treatment strategies for transplant‐associated
thrombotic microangiopathy (TA‐TMA) have not proven to be very effective. Recently …

Outcomes of plasma exchange in patients with transplant‐associated thrombotic microangiopathy based on time of presentation since transplant

S Mulay, JD Kreuter, SC Bryant… - Journal of Clinical …, 2015 - Wiley Online Library
Transplant‐associated thrombotic microangiopathy (TA‐TMA) is a rare clinical syndrome
associated with significant mortality. Although the use of plasma exchange (PE) in TA‐TMA …

Thrombotic Microangiopathy Syndromes—Common Ground and Distinct Frontiers

RM Hanna, K Henriksen, K Kalantar-Zadeh… - Advances in chronic …, 2022 - Elsevier
Thrombotic microangiopathies (TMAs) have in common a terminal phenotype of
microangiopathic hemolytic anemia with end-organ dysfunction. Thrombotic …

Glomerular mRNA expression of prothrombotic and antithrombotic factors in renal transplants with thrombotic microangiopathy

PA Agustian, CL Bockmeyer, F Modde, J Wittig… - …, 2013 - journals.lww.com
Background Thrombotic microangiopathy (TMA) in renal transplants (rTx-TMA) is a serious
complication and is usually either recurrent TMA (RecTMA) due to humoral rejection (HR …